PubMed · 1998 · 77 citations · 0 references
Life SciencesMolecular BiologyOncologyGene ExpressionMolecular VirologyTranscriptional RegulationOncogenic VirusesViral HepatitisViral OncogenesisViral TranscriptionHepatitis B Virus-associated CarcinogenesisHost Cell TransformationLiver Tumor PromotionMolecular Mechanisms Of TransformationSoft Agar Colony Formation AssaysTranscriptional ActivationTranscriptional Activation ElementsViral Transformation
The ability of the hepatitis B virus (HBV)-encoded X protein (HBx) to coactivate transcription of viral and cellular genes has been implicated in the development of HBV-related liver cancer. To dissect the transformation and the transcription activation properties of HBx, we generated REV2 cell lines expressing the wild-type and different truncated versions of the protein. Full-length HBx-expressing REV-2 cells display an altered morphology and form large colonies in soft agar. A similar transformation efficiency has been obtained with a truncated version of HBx, which contains only the first 50 NH2-terminal amino acids (HBx 1-50). In contrast, HBx mutants that lack the NH2-terminal segment but retain most of the transactivating function, as compared to the full length HBx, were unable to alter the growth characteristic of REV-2 cells. Furthermore, abrogation of full-length HBx transcriptional activation by the insertion of two amino acids (Arg-Pro) at position 68 did not affect REV-2 cells transformation. These results demonstrate that the transactivation activity of HBx is neither essential nor sufficient for tumor promotion.